Surveillance of Antimicrobial Prescriptions in Community Pharmacies Located in Tokyo, Japan.
AMR Action Plan
DPY
antimicrobial prescription
antimicrobial stewardship policy in pediatric clinic
pharmacy
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
17 Aug 2023
17 Aug 2023
Historique:
received:
30
06
2023
revised:
10
08
2023
accepted:
15
08
2023
medline:
26
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
An antimicrobial resistance (AMR) Action Plan was launched in 2016 to prevent the spread of antimicrobial-resistant bacteria in Japan. Additional support for the appropriate use of pediatric antimicrobial agents was initiated in 2018 to promote the appropriate use of antimicrobial agents in the community. To evaluate the effectiveness of the AMR Action Plan in the community, we investigated antimicrobial prescriptions in community pharmacies. Data on prescriptions for antimicrobial agents dispensed in 42 community pharmacies located in the Tama district, Tokyo, Japan, were collected between April 2013 and December 2019. In this study, we employed the DPY, which was calculated as defined daily doses (DDDs)/1000 prescriptions/year. The DPY is the number of antimicrobial agents used (potency) per 1000 antimicrobial prescriptions dispensed in pharmacies per year. The number of prescriptions for third-generation cephalosporins, fluoroquinolones, and macrolides decreased after the initiation of the AMR Action Plan; the DPYs of these antimicrobial agents decreased significantly by 31.4%, increased by 15.8%, and decreased by 23.6%, respectively (
Identifiants
pubmed: 37627745
pii: antibiotics12081325
doi: 10.3390/antibiotics12081325
pmc: PMC10451865
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Pediatr Res. 2022 Apr;91(5):1036-1042
pubmed: 34120139
Int J Epidemiol. 2022 Oct 13;51(5):1645-1655
pubmed: 35353127
J Glob Antimicrob Resist. 2016 Aug 6;7:19-23
pubmed: 27973324
Int J Infect Dis. 2020 Feb;91:1-8
pubmed: 31730926
Paediatr Respir Rev. 2005 Sep;6(3):227-35
pubmed: 16153572
Res Social Adm Pharm. 2022 Jul;18(7):3184-3190
pubmed: 34556433
PLoS One. 2021 Mar 18;16(3):e0248338
pubmed: 33735299
BMC Health Serv Res. 2020 May 11;20(1):399
pubmed: 32393267
Antibiotics (Basel). 2022 May 18;11(5):
pubmed: 35625326
Infection. 2018 Apr;46(2):207-214
pubmed: 29273972
J Med Microbiol. 2018 Jun;67(6):769-774
pubmed: 29676727
Int J Infect Dis. 2021 Feb;103:154-156
pubmed: 33227519
J Infect Chemother. 2021 Nov;27(11):1584-1590
pubmed: 34246543
Antibiotics (Basel). 2021 Oct 22;10(11):
pubmed: 34827231
Auris Nasus Larynx. 2016 Apr;43(2):131-6
pubmed: 26441370
PLoS One. 2021 May 11;16(5):e0251299
pubmed: 33974635
Glob Health Med. 2020 Jun 30;2(3):164-167
pubmed: 33330801
J Infect Chemother. 2018 Jun;24(6):414-421
pubmed: 29428566
PLoS One. 2019 Oct 16;14(10):e0223835
pubmed: 31618258
J Infect Chemother. 2018 Jul;24(7):563-569
pubmed: 29628385
Auris Nasus Larynx. 2020 Aug;47(4):493-526
pubmed: 32576390
JAMA. 2017 Dec 19;318(23):2325-2336
pubmed: 29260224